Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Priority to UY31030ApriorityCriticalpatent/UY31030A1/en
Publication of UY31030A1publicationCriticalpatent/UY31030A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invencion proporciona compuestos de la formula (I) o sales de los mismos: que tienen actividad farmacologica, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y el uso de los mismos en el tratamiento de diferentes trastornos mediados por los receptores S1P1.The present invention provides compounds of the formula (I) or salts thereof: which have pharmacological activity, methods for their preparation, pharmaceutical compositions containing them and their use in the treatment of different disorders mediated by S1P1 receptors.
PHARMACEUTICAL COMPOSITION THAT INCLUDES DERIVATIVES OF GLUCOPIRANOSIL DIFENYLMETHANE, PHARMACEUTICAL FORM OF THE SAME, PROCEDURE FOR THEIR PREPARATION AND USES OF THE SAME FOR IMPROVED GLUCEMIC CONTROL IN A PATIENT.
Compounds derived from imidazopyrimidine, substituted, pde10a inhibitors; preparation procedure; pharmaceutical composition; and its use for the treatment or prevention of psychotic disorders, schizophrenia, parkinson's disease, multiple sclerosis, among others.
Compounds derived from pyrrolidin-2-carboxamide, p53-mdm2 interaction inhibitors; pharmaceutical composition that includes them; and its use in the preparation of useful medicines for the treatment of cancer.